Community Pharmacy England is seeking an Independent Chair to provide strategic leadership and oversight of its Committee. This important role involves steering the Committee’s work as the governing body, supporting the executive team managing and engaging with external stakeholders. With our current Chair, Sue Killen, due to complete her term of office later this year,
Read moreNHS England has announced that GP Connect Access Record: Structured is being rolled out to hundreds of community pharmacies. This functionality enables pharmacies to view real-time, read-only information from patient records held by GP practices, supporting timely and informed care. The rollout is being coordinated by the four assured Community Pharmacy Contractual Framework (CPCF) IT
Read moreIn response to a significant ongoing disruption to the supply of Estradot® 25micrograms/24hours patches, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 3rd April 2025, SSP082, provides that for every Estradot® 25micrograms/24hours patch originally prescribed either one Evorel® 25 patch or one Estraderm® MX
Read moreThe Drug Tariff Category M pricelist for April 2025 has been published on the NHS Business Services Authority (NHSBSA) website. This price list includes a margin increase of +£12.3m per quarter, as the result of the CPCF settlement announced for 2024/25 and 2025/26. Without the agreed uplifts included in the settlement, the margin adjustment would have
Read moreMHRA Class 3 Medicines Recall: Urospir 50mg/5ml Oral Solution Drug Alert Number: EL(25)A/14 Date issued: 02 April 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall notice for: Urospir 50mg/5ml Oral Solution DMRC reference number: DMRC-35150350 Marketing Authorisation Holder:Rosemont Pharmaceuticals Ltd Product name: Urospir 50mg/5ml Oral Solution SNOMED code:
Read moreThe NHS Business Services Authority (NHSBSA) has published updates to the April Drug Tariff to include details from the CPCF arrangements for 2025/26. These updates can be found on the NHSBSA website here and include the following: Part I – Changes to the Payment Timetable to include earlier fee payments for the Hypertension Case Finding Service
Read moreThe following price concessions granted in March 2025 have rolled over to April 2025: Drug Pack size March 2025 price concession Fusidic acid 1% modified-release eye drops 5 £21.00 Oxybutynin 2.5mg tablets 56 £1.11 Timolol 0.5% eye drops 5 £1.63 Venlafaxine 300mg modified-release tablets 30 £43.09 Please note any rolled over prices can be adjusted
Read moreDrug alert number: EL (25)A/13 Date issued: 01 April 2025 Uni Health Distribution Ltd has informed the MHRA of a typographical error on the approved carton overlabel for certain batches of Utrogestan Vaginal 200 mg Capsules. The carton label references ‘micrograms’ where it should actually state ‘milligrams’. Utrogestan Vaginal 200 mg Capsules, PLPI 45396/0316 Batch
Read moreThe Lateral flow device tests supply service for patients potentially eligible for COVID-19 treatments (LFD service) will continue to be commissioned as an Advanced service through 2025/26. NHS England has also confirmed the fee for provision of the service will increase to £4.10 + VAT from 1st April 2025, following a request from Community Pharmacy
Read moreFrom 1 April 2025, Progesterone micronised 200mg capsules (Gepretix®) has been added to the list of medicines covered by the HRT prepayment certificate (HRT PPC). This change has been reflected in Part XVI of the April 2025 Drug Tariff and on the NHSBSA’s website. Community Pharmacy England has also updated its HRT medicines list to
Read more
